Positron Emission Tomography Studies Using (15R)-16-m-[11C]tolyl-17,18,19,20-tetranorisocarbacyclin Methyl Ester for the Evaluation of Hepatobiliary Transport
Authors:
- Tadayuki TakashimaTTTadayuki Takashima
- Hiroko NagataHNHiroko Nagata
- Takahiro NakaeTNTakahiro Nakae
- Yilong CuiYCYilong Cui
- Yasuhiro WadaYWYasuhiro Wada
- Satoshi KitamuraSKSatoshi Kitamura
- Hisashi DoiHDHisashi Doi
- Masaaki SuzukiMSMasaaki Suzuki
- Kazuya MaedaKMKazuya Maeda
- Hiroyuki KusuharaHKHiroyuki Kusuhara
- Yuichi SugiyamaYSYuichi Sugiyama
- Yasuyoshi WatanabeYWYasuyoshi Watanabe
- 1 November 2010
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 335 (2) , 314-323
Abstract
A quantitative positron emission tomography (PET) methodology was developed for in vivo kinetic analysis of hepatobiliary transport. Serial abdominal PET scans were performed on normal and multidrug resistance-associated protein 2 (Mrp2)-deficient rats after intravenous injection of (15R)-16-m-[11C]tolyl-17,18,19,20-tetranorisocarbacyclin methyl ester (15R-[11C] TIC-Me) as a radiotracer. 15R-[11C]TIC-Me was rapidly converted to its acid form in blood within 10 s. PET scans revealed that 15R-[11C]TIC was localized mainly in the liver within 5 min of injection. By 90 min, total radioactivity in bile of Mrp2-deficient rats was significantly reduced compared with controls. Metabolite analysis by thin-layer chromatography autoradiography showed that 15R-[11C]TIC is converted to at least three metabolites (M1, M2, and M3), and M2 and M3 are the major metabolites in plasma and bile, respectively. Hepatic uptake clearance of total radioactivity in normal rats was close to the hepatic blood flow rate and slightly higher than that in Mrp2-deficient rats. The intrinsic canalicular efflux clearance of M3 (CLint,bile,M3) in Mrp2-deficient rats was decreased to 12% of controls, whereas clearance of M2 was moderately decreased (54%). An in vitro transport assay detected ATP-dependent uptake of both M2 and M3 by rat Mrp2-expressing membrane vesicles. These results demonstrated that M3 is excreted primarily into the bile by Mrp2 in normal rats. We conclude that PET studies using 15R-[11C]TIC-Me could be useful for in vivo analyses of Mrp2-mediated hepatobiliary transport.Keywords
This publication has 35 references indexed in Scilit:
- 1-11C-Methyl-4-Piperidinyl-N-Butyrate Radiation Dosimetry in Humans by Dynamic Organ-Specific EvaluationJournal of Nuclear Medicine, 2008
- Neuroprotection by a Central Nervous System–Type Prostacyclin Receptor Ligand Demonstrated in Monkeys Subjected to Middle Cerebral Artery Occlusion and ReperfusionStroke, 2006
- Identification of the Hepatic Efflux Transporters of Organic Anions Using Double-Transfected Madin-Darby Canine Kidney II Cells Expressing Human Organic Anion-Transporting Polypeptide 1B1 (OATP1B1)/Multidrug Resistance-Associated Protein 2, OATP1B1/Multidrug Resistance 1, and OATP1B1/Breast Cancer Resistance ProteinThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Involvement of BCRP (ABCG2) in the Biliary Excretion of PitavastatinMolecular Pharmacology, 2005
- Rapid methylation on carbon frameworks leading to the synthesis of a PET tracer capable of imaging a novel CNS-type prostacyclin receptor in living human brainTrAC Trends in Analytical Chemistry, 2004
- In vitro and in vivo hepatic transport of the magnetic resonance imaging contrast agent B22956/1: role of MRP proteinsBiochemical and Biophysical Research Communications, 2002
- Synthesis of 11C/13C-Labelled Prostacyclins.Acta Chemica Scandinavica, 1998
- Noninvasive assessment of hepatobiliary and renal elimination of cysteinyl leukotrienes by positron emission tomographyHepatology, 1995
- Organic anion transport study in mutant rats with autosomal recessive conjugated hyperbilirubinemiaLife Sciences, 1991
- Kinetic Analysis of In Vivo Receptor-Dependent Binding of Human Epidermal Growth Factor by Rat TissuesJournal of Pharmaceutical Sciences, 1988